Subscribe to Bio.News Weekly Newsletter
Get Bio.News in your inbox every Monday morning.
SubscribeNo spam. Just science. Unsubscribe at any time.
WATCH THE LATEST FROM BIO 2026
Latest News
iNFixion seeks NF1 treatment by enhancing what the body is doing right
The BIO 2026 Start-up Stadium winner targets a rare disease. As Herb Sarnoff sits in the hospital, waiting for a...
With pharmaceutical tariffs looming, guidance on compliance is still lacking
With tariffs on patented pharmaceuticals and input materials set to take effect for all companies on Sept. 29, the lack...
Strong IP ecosystems drive biotech R&D and investment, report shows
Stronger intellectual property protection statistically correlates with increased development of cutting-edge therapies and greater investment in life sciences research, according...
Affordability and Access: Why patient perspectives matter
“Context around patient-identified affordability and access challenges is really critical,” began Karin Hoelzer, DVM, PhD, Senior Director, Patient Advocacy during...
BIO 2026: Are we entering the ‘golden era’ of women’s health?
For years, advocates have pushed for more research and investment in women’s health. Now, it may be paying off. “I’m...
BIO applauds efforts targeting early drug development efficiency, provides suggestions
A Food and Drug Administration (FDA) pilot program to expedite approval of new drugs contains potentially impactful initiatives but risks...